This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Merck Patent Gmbh. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Lukas Shinji Okitsu: Innovator in TLR7/8 Antagonists
Introduction
Lukas Shinji Okitsu is a notable inventor based in Billerica, MA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of TLR7/8 antagonists. His work is recognized for its potential applications in various therapeutic areas.
Latest Patents
Lukas holds a patent for "TLR7/8 antagonists and uses thereof." This patent discloses compounds that are useful as TLR7/8 antagonists, along with pharmaceutically acceptable compositions. His innovative approach in this area has the potential to impact treatment options significantly.
Career Highlights
Lukas is currently associated with Merck Patent GmbH, where he continues to advance his research and development efforts. His expertise in pharmacology and drug development has positioned him as a valuable asset in the industry.
Collaborations
Lukas has collaborated with notable colleagues, including Julie DeMartino and Thomas Spangenberg. These partnerships have fostered a collaborative environment that enhances the innovation process.
Conclusion
Lukas Shinji Okitsu is a prominent figure in the field of pharmaceutical innovation, particularly known for his work on TLR7/8 antagonists. His contributions are paving the way for new therapeutic possibilities.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile